Lowest Price Guaranteed From USD 4,799
Published
January 2023
Pages
165
View Count
3345
Example Insights
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Report Description
The global blockchain in healthcare market size is estimated to be worth USD 58 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 22%, during the forecast period. The conventional healthcare industry was plagued with various challenges, including fragmented medical records, lack of data integrity, interoperability issues, supply chain management inefficiencies and security breach of patient’s sensitive medical information. Further, approximately 80% of the medical studies fail to produce the desired results due to errors such as fraud, data falsification and trial misconduct. It is important to mention that more than 690 healthcare data breaches were reported between July 2021 and June 2022. As a result, the adoption of blockchain technology (also referred to as distributed ledger technology (DLT)), has emerged to be a promising approach. This innovative technology appropriately identifies dangerous mistakes in the medical industry; it also facilitates safe storage and management of healthcare data and transactions. In addition, the blockchain applications include clinical trials (to prevent data manipulation and enhance transparency of clinical trial data), supply chain management (to reduce the prevalence of counterfeit medications / drugs), telemedicine (to protect medical records from unauthorized access or tampering) and electronic medical records (to facilitate patients’ data security between different healthcare providers).
The Blockchain in Healthcare Market: Distribution by Application (Drug Discovery, Clinical Trials) Type of Blockchain (Public Blockchain, Private Blockchain, Hybrid Blockchain, and Other Blockchains), Type of End User (Hospitals, Pharmaceutical Industry, Research Institutes and Academic Institutes), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 market report features an extensive study of the current market landscape, market size and future opportunity for the companies offering blockchain technology in healthcare market for application in drug discovery and clinical trials, during the given forecast period. Key takeaways from the market report are briefly discussed below.
Blockchain is a decentralized, distributed, digital ledger that is used to record transactions on a common digital platform. It is worth noting, that the record cannot be altered retroactively without the alteration of all subsequent blocks and the consensus of the network. Further, the technology was developed to facilitate secure transactions between different stakeholders, without involving third parties. There are few simple steps on which blockchain works:
The current market landscape features more than 50 companies that are engaged in offering blockchain technology for healthcare industry. Overall, the market seems to be well-fragmented, featuring the presence of very small, small, mid-sized, large, and very large companies. More than 50% of the companies engaged in this industry are headquartered in North America, followed by companies based in Europe (32%). Some examples of blockchain platform providers, include ConsenSys, Embleema, Equideum Health, IBM lifescience, MELLODDY and Pistoia Alliance.
Majority (56%) of the blockchain technology platform providers offer public blockchain; these are also referred to as permissionless blockchain that allow anyone to participate in the network. Further, the blockchain technology platforms are primarily used in clinical trial management for patient data management, operational excellence, and patient recruitment and retention.
Several stakeholders have been forging alliances related to blockchain in healthcare, specifically for application in drug discovery and clinical trials with pharmaceutical companies for platform utilization, platform integration and platform development purposes. It is interesting to note that in September 2022, Mayo Clinic entered into a partnership with Triall to use the latter company’s blockchain platform, to optimize the integrity of the former company’s clinical trial design and manage healthcare data. Further, in March 2022, Triall entered into an agreement with Crucial Data Solutions to integrate its blockchain platform with the latter company’s eClinical solutions; both the companies aim to strengthen data security and integrity. The collaboration of blockchain companies with other technology providers will help in increasing the applicability of the platform specifically for conducting / supporting decentralized clinical trials. Such trends will drive the blockchain in healthcare market growth during the forecast period.
Market Trend Analysis: Increase in Publications Reflect the Rising Interest in Blockchain in Healthcare Market
More than 510 scientific articles related to this industry have been published (in journals having different impact factors), over a period of six years, highlighting the substantial efforts made by researchers. Around 60% of these publications were research articles. In addition, the maximum number of articles focused on blockchain technology in the pharma sector were published by Multidisciplinary Digital Publishing Institute (MDPI), followed by Journal of Medical Internet Research and Frontiers Media.
The blockchain in healthcare market, for application in drug discovery and clinical trials, in Asia-Pacific is likely to capture the largest market share (46%). Additionally, in terms of type of blockchain, public blockchain is anticipated to capture maximum share in the market, in the foreseen future. In terms of end user, presently, around 40% of the revenue generation potential is associated with hospitals using proprietary blockchain platforms for drug discovery and clinical trials. The blockchain in healthcare market is valued at USD 58 million in 2023 and is anticipated to grow at a CAGR of 22% during the forecast period.
In recent years, the use of blockchain has been on the rise, driven by the growing demand for methods that safeguard sensitive healthcare data, shift towards digital health records and ongoing technological advancements. Blockchain provides a strong platform for enhanced clinical practice in terms of maintaining patient records and enrolling patients for trials. It also enhances the storage and transparency of medical data. In addition, the ledger can be used to contain all the updated information along with an encrypted patient identity to secure patient data. Owing to the benefits offered by blockchain technology in healthcare, we expect the pharmaceutical companies to start adopting the platform for clinical trials, supporting the market growth over the forecast period. In July 2022, Japan based Aculys Pharma announced its plans to use a blockchain platform from SUSMED to conduct a clinical trial.
Examples of key companies offering blockchain technology in healthcare market (which have also been captured in this market report) include (in alphabetic order) Alten Calsoft Labs, ConsenSys, Humanscape, Hyperledger Foundation, IBM, Infosys, Innoplexus, Medsphere, Solulab Stratumn and Tech Mahindra. This market report includes an easily searchable, excel database of all the companies offering blockchain for healthcare applications.
Several recent developments have taken place in the field of blockchain in healthcare market, some of which have been outlined below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analysis.
The blockchain in healthcare market report features an in-depth analysis of various firms / organizations that are engaged in this industry, across different segments as defined in the below table:
Key Report Attributes | Details | |
Base Year |
2023 |
|
Forecast Period |
2023 – 2035 |
|
Market Size 2023 |
$58 million | |
CAGR |
22% |
|
Type of Blockchain |
|
|
Type of End User |
|
|
Key Geographical Regions |
|
|
Key Companies Profiled |
|
|
PowerPoint Presentation (Complimentary) |
|
|
Customization Scope |
|
|
Excel Data Packs (Complimentary) |
|
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this industry, across different geographies. Amongst other elements, the research report features:
One of the key objectives of the blockchain in healthcare market report was to estimate the current opportunity and future growth potential of blockchain in drug discovery and clinical trials market over the forecast period. We have provided informed estimates on the likely evolution of the market for the forecast period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of blockchain (public blockchain, private blockchain, hybrid blockchain, and other blockchains), type of end user (hospitals, pharmaceutical industry, research institutes and academic institutes) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the world). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.
The opinions and insights presented in the market report were influenced by discussions held with stakeholders in this industry. The research report features detailed transcripts of interviews held with the industry stakeholders.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Contents
1. PREFACE
1.1. Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5 Key Questions Answered
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
2.1 Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Blockchain Technology
3.2.1. Ethereum vs Hyperledger Fabric
3.3. Types of Blockchain
3.3.1. Permissionless or Public Blockchain
3.3.2. Permissioned or Private Blockchain
3.3.3. Federated or Consortium Blockchain
3.4. Applications of Blockchain Across Various Industries
3.5. Applications of Blockchain in Drug Discovery and Clinical Trials
3.6. Advantages and Limitations of Blockchain
3.7. Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. List of Blockchain Technology Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Year of Establishment, Company Size, and Region of Headquarters
4.2.6. Analysis by Type of Blockchain(s)
4.2.7. Analysis by Type of Drug Development Application(s)
4.2.8. Analysis by Application(s) within Clinical Trial Management
4.2.9. Analysis by Type of End-User(s)
4.2.10. Analysis by Type of Blockchain and Type of End-User(s)
4.2.11. Analysis by Type of Blockchain and Type of Drug Development Application(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Blockchain Technology Providers based inNorth America (Peer Group I)
5.5. Company Competitiveness Analysis: Blockchain Technology Providers based inEurope (Peer Group II)
5.6. Company Competitiveness Analysis: Blockchain Technology Providers based inAsia Pacific and RoW (Peer Group III)
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Alten Calsoft Labs
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Application Areas of Proprietary Platform
6.2.4. Recent Developments and Future Outlook
6.3. ConsenSys
6.3.1. Company Overview
6.3.2. Application Areas of Proprietary Platform
6.3.3. Recent Developments and Future Outlook
6.4. IBM
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Application Areas of Proprietary Platform
6.4.4. Recent Development and Future Outlooks
6.5. Stratumn
6.5.1. Company Overview
6.5.2. Application Areas of Proprietary Platform
6.5.3. Recent Development and Future Outlook
6.6. Infosys
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Application Areas of Proprietary Platform
6.6.4. Recent Developments and Future Outlook
6.7. Tech Mahindra
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Application Areas of Proprietary Platform
6.7.4. Recent Developments and Future Outlook
6.8. Humanscape
6.8.1. Company Overview
6.8.2. Application Areas of Proprietary Platform
6.8.3. Recent Developments and Future Outlook
6.9. Hyperledger Foundation
6.9.1. Company Overview
6.9.2. Application Areas of Proprietary Platform
6.9.3. Recent Developments and Future Outlook
6.10. Innoplexus
6.10.1. Company Overview
6.10.2. Application Areas of Proprietary Platform
6.10.3. Recent Developments and Future Outlook
6.11. Medsphere
6.11.1. Company Overview
6.11.2. Application Areas of Proprietary Platform
6.11.3. Recent Developments and Future Outlook
6.12. Solulab
6.12.1. Company Overview
6.12.2. Application Areas of Proprietary Platform
6.12.3. Recent Developments and Future Outlook
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3 Blockchain in Drug Discovery and Clinical Trials: Recent Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Company Size and Type of Partnership
7.3.5. Most Active Players: Distribution by Number of Partnerships
7.3.6. Most Active Players: Distribution by Type of Partnership
7.3.7. Analysis by Type of Pharmaceutical Applications
7.3.8. Analysis by Type of Partner
7.3.9. Analysis by Geographical Region
7.3.9.1. Local and International Agreements
7.3.9.2. Intercontinental and Intracontinental Agreements
8. PUBLICATION ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Blockchain Technology in Pharmaceutical Industry: Recent Publications
8.3.1. Analysis by Year of Publication
8.3.2. Analysis by Type of Article
8.3.3. Popular Journals: Analysis by Number of Publications
8.3.4. Popular Publishers: Analysis by Number of Publications
8.3.5. Popular Copyright Holders: Analysis by Number of Publications
8.3.6. Analysis by Popular Keywords
8.3.7. Analysis by Impact Factor
8.3.8. Popular Journals: Analysis by Journal Impact Factor
9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Blockchain in Drug Discovery and Clinical Trials: SWOT Analysis
9.3. Comparison of SWOT Factors
9.3.1. Strengths
9.3.1.1. Transparency and Traceability
9.3.1.2. Cost Reduction and Data Integrity
9.3.1.3. Safe and Secure Transactions
9.3.1.4. Patient Data Management
9.3.2. Weaknesses
9.3.2.1. Implementation Expense
9.3.2.2. Storage
9.3.2.3. Immutability of Data
9.3.2.4. High Energy Consumption
9.3.3. Threats
9.3.3.1. Blockchain is Prone to Cyber Attacks
9.3.3.2. Scalability
9.3.3.3. Lack of Regulations Issued by Legal Authorities
9.3.4. Opportunities
10. CASE STUDY: APPLICATIONS OF BLOCKCHAIN IN HEALTHCARE AND OTHER INDUSTRIES
10.1. Chapter Overview
10.2. Applications of Blockchain Across Various Industries
10.2.1 Blockchain in Healthcare
10.2.2. Blockchain in Banking and Financial Industry
10.2.3. Blockchain in Automotive Industry
10.2.4. Blockchain in Education
10.2.5. Blockchain in Telecom Industry
10.2.6. Blockchain in Transportation
10.2.7. Blockchain in Travel Industry
11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035
11.4. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035
11.4.1. Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035
11.4.2. Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035
11.4.3. Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035
11.4.4. Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035
11.5. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035
11.5.1. Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035
11.5.2. Blockchain in Drug Discovery and Clinical Trials Market forPharmaceutical Industry, 2023-2035
11.5.3. Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035
11.5.4. Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035
11.6. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035
11.6.1. Blockchain in Drug Discovery and Clinical Trials Market in NorthAmerica, 2023-2035
11.6.2. Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035
11.6.3. Blockchain in Drug Discovery and Clinical Trials Market in Asia-Pacific, 2023-2035
11.6.4. Blockchain in Drug Discovery and Clinical Trials Market in Rest of theWorld, 2023-2035
12. CONCLUDING REMARKS
13. EXECUTIVE INSIGHTS
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Historical Evolution of Blockchain Technology
Figure 3.2 Types of Blockchain
Figure 3.3 Applications of Blockchain Across Various Industries
Figure 3.4 Advantages and Limitations of Blockchain
Figure 4.1 Blockchain Technology Providers: Distribution by Year of Establishment
Figure 4.2 Blockchain Technology Providers: Distribution by Company Size
Figure 4.3 Blockchain Technology Providers: Distribution by Region of Headquarters
Figure 4.4 Blockchain Technology Providers: Distribution by Location of Headquarters
Figure 4.5 Blockchain Technology Providers: Distribution Year of Establishment, Company Size, and Region of Headquarters
Figure 4.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
Figure 4.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
Figure 4.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
Figure 4.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
Figure 4.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
Figure 4.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
Figure 5.1 Company Competitiveness Analysis: Blockchain Technology Providers based in North America (Peer Group I)
Figure 5.2 Company Competitiveness Analysis: Blockchain Technology Providers based in Europe (Peer Group II)
Figure 5.3 Company Competitiveness Analysis: Blockchain Technology Providers based in Asia Pacific and RoW (Peer Group III)
Figure 6.1 Alten Calsoft Labs: Annual Revenues, 2018- H1 2022 (EUR Billion)
Figure 6.2 Alten Calsoft Labs: Application Areas of Proprietary Platform
Figure 6.3 ConsenSys: Application Areas of Proprietary Platform
Figure 6.4 IBM: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.5 IBM: Application Areas of Proprietary Platform
Figure 6.6 Stratumn: Application Areas of Proprietary Platform
Figure 6.7 Infosys: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.8 Infosys: Application Areas of Proprietary Platform
Figure 6.9 Tech Mahindra: Annual Revenues, 2018- H1 2022 (USD Billion)
Figure 6.10 Tech Mahindra: Application Areas of Proprietary Platform
Figure 7.1 Partnerships and Collaborations: Distribution by Year of Partnership, 2017-2022
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Figure 7.5 Most Active Partners: Distribution by Number of Partnerships
Figure 7.6 Most Active Players: Distribution by Type of Partnership
Figure 7.7 Partnerships and Collaborations: Distribution by Type of Pharmaceutical Applications
Figure 7.8 Partnerships and Collaborations: Distribution by Type of Partner
Figure 7.9 Partnerships and Collaborations: Local and International Agreements
Figure 7.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.1 Publication Analysis: Cumulative Year-wise Trend, 2016-2022
Figure 8.2 Publication Analysis: Distribution by Type of Article
Figure 8.3 Popular Journals: Distribution by Number of Publications
Figure 8.4 Popular Publishers: Distribution by Number of Publications
Figure 8.5 Popular Copyright Holders: Distribution by Number of Publications
Figure 8.6 Word Cloud: Key Focus Areas
Figure 8.7 Publication Analysis: Distribution by Impact Factor
Figure 8.8 Popular Journals: Distribution by Journal Impact Factor
Figure 9.1 Blockchain Technology in Pharmaceutical Industry: SWOT Analysis
Figure 9.2 SWOT Factors: Harvey Ball Analysis
Figure 10.1 Key Applications of Blockchain Across Various Industries
Figure 11.1 Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035 (USD Million)
Figure 11.2 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035 (USD Million)
Figure 11.3 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035 (USD Million)
Figure 11.4 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035 USD Million)
Figure 11.5 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035 USD Million)
Figure 11.6 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035 (USD Million)
Figure 11.7 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035 (USD Million)
Figure 11.8 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035 (USD Million)
Figure 11.9 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, 2023- 2035 (USD Million)
Figure 11.10 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035 (USD Million)
Figure 11.11 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035 (USD Million)
Figure 11.12 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Figure 11.13 Blockchain in Drug Discovery and Clinical Trials Market in North America, 2023-2035 (USD Million)
Figure 11.14 Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035 (USD Million)
Figure 11.15 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, 2023-2035 (USD Million)
Figure 11.16 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Blockchain Technology Providers Market Landscape
Figure 12.2 Concluding Remarks: Partnerships and Collaborations
Figure 12.3 Concluding Remarks: Publication Analysis
Figure 12.4 Concluding Remarks: SWOT Analysis
Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 List of Blockchain Technology Providers
Table 4.2 Blockchain Technology Providers: Information on Type of Blockchain(s)
Table 4.3 Blockchain Technology Providers: Information on Type of Drug Development Application(s)
Table 4.4 Blockchain Technology Providers: Information on Application(s) within Clinical Trial Management
Table 4.5 Blockchain Technology Providers: Information on Type of End-User(s)
Table 6.1 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
Table 6.2 Alten Calsoft Labs: Key Highlights
Table 6.3 Alten Calsoft Labs: Recent Developments and Future Outlook
Table 6.4 ConsenSys: Key Highlights
Table 6.5 ConsenSys: Recent Developments and Future Outlook
Table 6.6 IBM: Key Highlights
Table 6.7 IBM: Recent Developments and Future Outlook
Table 6.8 Stratumn: Key Highlights
Table 6.9 Infosys: Key Highlights
Table 6.10 Infosys: Recent Developments and Future Outlook
Table 6.11 Tech mahindra: Key Highlights
Table 6.12 Tech Mahindra: Recent Developments and Future Outlook
Table 6.13 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
Table 6.14 Humanscape: Key Highlights
Table 6.15 Humanscape: Application Areas of Proprietary Platform
Table 6.16 Humanscape: Recent Developments and Future Outlook
Table 6.17 Hyperledger Foundation: Key Highlights
Table 6.18 Hyperledger Foundation: Application Areas of Proprietary Platform
Table 6.19 Hyperledger Foundation: Recent Developments and Future Outlook
Table 6.20 Innoplexus: Key Highlights
Table 6.21 Innoplexus: Application Areas of Proprietary Platform
Table 6.22 Innoplexus: Recent Developments and Future Outlook
Table 6.23 Medsphere: Key Highlights
Table 6.24 Medsphere: Application Areas of Proprietary Platform
Table 6.25 Medsphere: Recent Developments and Future Outlook
Table 6.26 Solulab: Key Highlights
Table 6.27 Solulab: Application Areas of Proprietary Platform
Table 6.28 Solulab: Recent Developments and Future Outlook
Table 7.1 Blockchain in Drug Discovery and Clinical Trials: List of Partnerships and Collaborations, 2017-2022
Table 10.1 Blockchain Technology in Education: Use Cases
Table 14.1 Blockchain Technology Providers: Distribution by Year of Establishment
Table 14.2 Blockchain Technology Providers: Distribution by Company Size
Table 14.3 Blockchain Technology Providers: Distribution by Region of Headquarters
Table 14.4 Blockchain Technology Providers: Distribution by Location of Headquarters
Table 14.5 Blockchain Technology Providers: Distribution by Year of Establishment, Company Size, and Region of Headquarters
Table 14.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
Table 14.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
Table 14.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
Table 14.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
Table 14.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
Table 14.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
Table 14.12 Alten Calsoft Labs: Annual Revenues, 2018-H1 2022 (EUR Billion)
Table 14.13 IBM: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.14 Infosys: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.15 Tech Mahindra: Annual Revenues, 2018-H1 2022 (USD Billion)
Table 14.16 Partnerships and Collaborations: Distribution by Year of Partnership, 2017- 2022
Table 14.17 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.18 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2017-2022
Table 14.19 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Table 14.20 Most Active Players: Distribution by Number of Partnerships
Table 14.21 Most Active Players: Distribution by Type of Partnerships
Table 14.22 Partnerships and Collaborations: Distribution by Type of PharmaceuticalApplications
Table 14.23 Partnerships and Collaborations: Distribution by Type of Partner
Table 14.24 Partnerships and Collaborations: Local and International Agreements
Table 14.25 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 14.26 Publication Analysis: Cumulative Year-Wise Trend, 2016-2022
Table 14.27 Publication Analysis: Distribution by Type of Article
Table 14.28 Popular Journals: Distribution by Number of Publications
Table 14.29 Popular Publishers: Distribution by Number of Publications
Table 14.30 Popular Copyright Holders: Distribution by Number of Publications
Table 14.31 Publication Analysis: Distribution by Impact Factor
Table 14.32 Popular Journals: Distribution by Journal Impact Factor
Table 14.33 Blockchain in Drug Discovery and Clinical Trials Market 2023-2035, Conservative, Base, and Optimistic Scenarios, 2023-2035 (USD Million)
Table 14.34 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain, 2023 and 2035
Table 14.35 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, 2023-2035: Conservative, Base, and Optimistic Scenarios (USD Million)
Table 14.36 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.37 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.38 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.39 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User, 2023 and 2035
Table 14.40 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.41 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.42 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.43 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.44 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions, 2023 and 2035
Table 14.45 Blockchain in Drug Discovery and Clinical Trials Market in North America, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.46 Blockchain in Drug Discovery and Clinical Trials Market in Europe, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.47 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
Table 14.48 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, 2023-2035: Conservative, Base and Optimistic Scenarios, (USD Million)
The following companies and organizations have been mentioned in the report:
Source 1: https://www.researchgate.net/publication/343180596_Applications_of_Blockchain_Technology_in_Clinical_Trials_Review_and_Open_Challenges
Source 2: https://www.geeksforgeeks.org/advantages-and-disadvantages-of-blockchain/